Levaquin Peripheral Neuropathy Lawsuit News: FDA Advisory Panels to Review Fluoroquinolone Antibiotics, Bernstein Liebhard LLP Reports

October 26, 2015 (PRLEAP.COM) Business News
October 26, 2015 - As Levaquin lawsuits (http://www.levaquinlawsuitcenter.com/) and other legal claims involving fluoroquinolone antibiotics continued to mount in U.S. courts, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has scheduled an advisory panel meeting to address safety concerns associated with these medications. According to the agency, the Antimicrobial Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee will meet on November 5, 2015, to discuss the risks and benefits of fluoroquinolone treatment for certain indications. The committees will be asked to make recommendations to the FDA about what regulatory actions should be taken regarding the use and safety of these antibiotics.

"Hundreds of plaintiffs are currently pursuing product liability claims over peripheral neuropathy and serious nerve injuries allegedly related to the use of Levaquin and other fluoroquinolone antibiotics. Our Firm has received inquiries from a number of individuals who may have been harmed by these medications, and we will be monitoring this meeting very closely," says Sandy A. Liebhard LLP, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free, no-obligation Levaquin lawsuit reviews to patients who may have been harmed by one of these antibiotics.

Fluoroquinolone Litigation
Fluoroquinolone antibiotics, including Levaquin, Avelox and Cipro, are used to treat a variety of bacterial infections. Currently, nearly 200 Levaquin lawsuits and other fluoroquinolone claims are pending in a multidistrict litigation now underway in the U.S. District Court, District of Minnesota, all of which have been filed on behalf of patients who allegedly suffered peripheral neuropathy or permanent nerve damage related to the use of these medications. Plaintiffs claim that the drugs' manufacturers failed to provide doctors and patients with adequate warnings regarding the true potential for these complications. (In Re: Fluoroquinolone Products Liability Litigation MDL No. 2642)

The labels for Levaquin and other fluoroquinolone antibiotics have mentioned peripheral neuropathy and nerve damage since 2004. But plaintiffs assert that the labeling wrongly characterized the risk as rare, and suggested that nerve problems would subside once treatment with the drugs ended. In 2013, the FDA ordered fluoroquinolone manufacturers to strengthen their product labels to better reflect the rapid onset and potential permanence of peripheral neuropathy and nerve damage side effects.

Bernstein Liebhard LLP continues to provide Levaquin lawsuit reviews to individuals who allegedly experienced peripheral neuropathy or permanent nerve damage related to treatment with fluoroquinolone antibiotics. To learn more, please visit the firm's website. Free, no-obligation legal consultations can also be obtained by calling 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. The Firm was named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list for a dozen consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP

Share Article